Last reviewed · How we verify
Placebo Formula 515 — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo Formula 515 (Placebo Formula 515) — Assistance Publique - Hôpitaux de Paris. Placebo Formula 515 is an inert formulation with no active pharmaceutical ingredient, producing therapeutic effects through placebo mechanisms.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo Formula 515 TARGET | Placebo Formula 515 | Assistance Publique - Hôpitaux de Paris | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo Formula 515 CI watch — RSS
- Placebo Formula 515 CI watch — Atom
- Placebo Formula 515 CI watch — JSON
- Placebo Formula 515 alone — RSS
Cite this brief
Drug Landscape (2026). Placebo Formula 515 — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-formula-515. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing